Skip to main content
. 2018 Sep 21;40(6):3199–3212. doi: 10.3892/or.2018.6719

Figure 5.

Figure 5.

Risk score analysis of two prognostic signatures associated with overall survival in patients with LUAC. (A) 9-lncRNA signature LASiglnc-9 and (B) LASiglnc2-m3 signature. Survival status and duration of cases (top panels); risk score of lncRNA signature (middle panels); and heat map of LUAC-specific lncRNAs and mRNAs (bottom panels). CCNB1, cyclin B1; KIF23, kinesin family member 23; E2F7, E2F transcription factor 7; LUAC, lung adenocarcinoma.